Press releases Image EN FR Corporate / 08.02.2024 IBA acquires Radcal Corporation to expand Medical Imaging Quality Assurance offering and strengthen US presence Read more IBA acquires Radcal Corporation to expand Medical Imaging Quality Assurance offering and strengthen US presence
Press releases Image FR EN Corporate / 05.02.2024 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR Corporate / 01.02.2024 IBA launches Oncia Community, a public utility foundation, dedicated to humanizing cancer care. Read more IBA launches Oncia Community, a public utility foundation, dedicated to humanizing cancer care.
Press releases Image FR EN Corporate / 31.01.2024 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR RadioPharma Solutions / 23.01.2024 iThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone® 70 Read more iThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone® 70
Press releases Image FR EN Corporate / 09.01.2024 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR Proton Therapy / 21.12.2023 IBA signs contract for a Proteus®ONE proton therapy system to be located at the Greater Poland Cancer Center Read more IBA signs contract for a Proteus®ONE proton therapy system to be located at the Greater Poland Cancer Center
Press releases Image EN FR RadioPharma Solutions / 20.12.2023 IBA celebrates a new milestone with the sale of the 100th Cyclone® KIUBE cyclotron Read more IBA celebrates a new milestone with the sale of the 100th Cyclone® KIUBE cyclotron
Press releases Image EN FR RadioPharma Solutions / 13.12.2023 IBA, CMI and Life Molecular Imaging announce Japanese approval for the reimbursement of amyloid-PET diagnostic Neuraceq® in Alzheimer's disease Read more IBA, CMI and Life Molecular Imaging announce Japanese approval for the reimbursement of amyloid-PET diagnostic Neuraceq® in Alzheimer's disease
Press releases Image EN FR RadioPharma Solutions / 12.12.2023 IBA pioneers theranostic advancements, empowering the market to produce Astatine-211 Read more IBA pioneers theranostic advancements, empowering the market to produce Astatine-211
Press releases Image EN FR Proton Therapy / 05.12.2023 IBA signs research collaboration agreement with the University of Kansas Medical Center on FLASH technology Read more IBA signs research collaboration agreement with the University of Kansas Medical Center on FLASH technology
Press releases Image EN FR CN Corporate / 16.11.2023 IBA Business Update – Third Quarter 2023 Read more IBA Business Update – Third Quarter 2023
Press releases Image EN FR Corporate / 26.10.2023 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR CN Proton Therapy / 18.10.2023 IBA plans total system restoration on its first-ever proton therapy installation Read more IBA plans total system restoration on its first-ever proton therapy installation
Press releases Image EN FR CN Proton Therapy / 27.09.2023 IBA finalizes contract with Medtechnica Ltd for two Proteus®ONE proton therapy solutions at the Tel Aviv Sourasky Medical Center in Israel Read more IBA finalizes contract with Medtechnica Ltd for two Proteus®ONE proton therapy solutions at the Tel Aviv Sourasky Medical Center in Israel
Press releases Image FR EN Corporate / 20.09.2023 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image FR EN Corporate / 12.09.2023 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image FR EN Corporate / 07.09.2023 IBA – TRANSPARENCY NOTIFICATION art.15 Read more IBA – TRANSPARENCY NOTIFICATION art.15
Press releases Image EN FR Corporate / 31.08.2023 IBA Reports Half Year 2023 Results Read more IBA Reports Half Year 2023 Results
Press releases Image EN FR Corporate / 31.08.2023 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
